Angiochem, Inc.
Industry
- Biotechnology
- Large Molecule
- Drug Discovery Technologies
- Pharmaceuticals
Latest on Angiochem, Inc.
The table records clinical developments using data from Informa Pharma Intelligence’s Biomedtracker. It lists drugs for which an important event was recorded between November 18 and November 24, 2016,
With most of the biopharma industry and press on vacation in the waning days of 2011, Alexion Pharmaceuticals Inc. announced on December 29 a rather extraordinary acquisition. The Cheshire, CT rar
Multiple companies are currently trying to find new and better ways to treat inherited lysosomal storage disorders (LSD), which are responsible for more than fifty rare and orphan diseases. Although T
Geron Corp. CEO John Scarlett says it will “certainly be challenging” to provide data proving reversibility of liver abnormalities after patients stopped taking its oncologic imetelstat in trials, bu